In complicated UTI or pyelonephritis, cefepime-enmetazobactam increased success vs. piperacillin-tazobactam at 14 d.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 36745895.
- Also identified by DOI 10.7326/J22-0114.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Kaye KS, Belley A, Barth P, et al. <b>Effect of cefepime/enmetazobactam vs piperacillin/tazobactam on clinical cure and microbiological eradication in patients with complicated urinary tract infection or acute pyelonephritis: a randomized clinical trial.</b> JAMA. 2022;328:1304-14. 36194218.
Medical subject headings
- Pyelonephritis
- Urinary Tract Infections